Pelthos Therapeutics reported revenue of $26.51M and net income of -$48.49M for the quarter ended Jun 2026. This income statement covers 15 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||
| Revenue | 7.41M | 9.09M | 10.91M | 26.51M | |||||||||||
| Cost of RevenueCost of Rev | 2.32M | 1.67M | 1.67M | 5.28M | |||||||||||
| Gross Profit | 5.09M | 7.42M | 9.23M | 21.23M | |||||||||||
| Operating items | |||||||||||||||
| Amortization - Intangibles | 0.68M | 0.88M | 1.03M | 2.07M | |||||||||||
| Research & DevelopmentR&D | 0.19M | 0.05M | 0.05M | 2.29M | 0.47M | 0.01M | 0.41M | 0.28M | 0.19M | 0.52M | 0.14M | 0.37M | 0.19M | 0.79M | |
| Selling, General & AdministrativeSG&A | 0.48M | 0.54M | 0.66M | 1.06M | 0.79M | 1.21M | 1.63M | 1.54M | 1.64M | 2.72M | 19.63M | 18.47M | 21.10M | 48.78M | |
| Other Operating ExpensesOther Opex | 0.25M | 0.19M | 0.58M | 0.52M | 0.68M | 0.54M | 3.00M | 2.55M | 2.70M | 7.36M | |||||
| Operating ExpensesOpex | 0.91M | 0.78M | 1.29M | 3.88M | 1.93M | 1.76M | 2.05M | 1.82M | 1.83M | 3.23M | 22.77M | 21.39M | 23.99M | 56.92M | |
| Operating IncomeOp. Inc | -0.91M | -0.78M | -1.29M | -3.88M | -1.93M | -1.76M | -2.05M | -1.82M | -1.83M | -3.23M | -15.36M | -12.00M | -13.09M | -30.41M | |
| EBIT | -0.91M | -0.78M | -1.29M | -3.88M | -1.93M | -1.76M | -2.05M | -1.82M | -1.83M | -3.23M | -15.36M | -12.00M | -13.09M | -30.41M | |
| Non-operating items | |||||||||||||||
| Non Operating Interest Expenses | 0.04M | 0.11M | 0.13M | 0.22M | 1.35M | 1.31M | 2.35M | 4.74M | |||||||
| Non Operating IncomeNon Op. Inc. | -0.05M | -0.18M | -0.13M | -0.16M | -0.63M | -0.01M | 0.35M | -0.10M | -0.13M | -0.22M | -1.34M | -16.58M | -11.98M | -18.08M | |
| Net income details | |||||||||||||||
| EBT | -0.97M | -0.95M | -1.42M | -4.04M | -2.56M | -1.77M | -1.70M | -1.93M | -1.97M | -3.45M | -16.70M | -28.59M | -25.07M | -48.49M | |
| Tax ProvisionsTaxes | -0.47M | -6.92M | |||||||||||||
| Profit After TaxPAT | -0.97M | -0.95M | -1.42M | -4.04M | -2.56M | -1.77M | -1.70M | -1.93M | -1.97M | -3.45M | -16.24M | -21.66M | -25.07M | -48.49M | |
| Income from Continuing OperationsIncome (Continuing) | -0.97M | -0.95M | -1.42M | -4.04M | -2.56M | -1.77M | -1.70M | -1.93M | -1.97M | -3.45M | -16.24M | -21.66M | -25.07M | -48.49M | |
| Consolidated Net IncomeConsol Net Inc. | -0.97M | -0.95M | -1.42M | -4.04M | -2.56M | -1.77M | -1.70M | -1.93M | -1.97M | -3.45M | -16.24M | -21.66M | -25.07M | -48.49M | |
| Income towards Parent CompanyParent Net Inc | -0.97M | -0.95M | -1.42M | -4.04M | -2.56M | -1.77M | -1.70M | -1.93M | -1.97M | 3.50M | -16.24M | -21.66M | -25.07M | -48.49M | |
| Net Income towards Common StockholdersNet Income | -0.97M | -0.95M | -1.42M | -4.04M | -2.56M | -1.77M | -1.70M | -1.93M | -1.97M | 3.50M | -16.24M | -21.66M | -25.07M | -48.49M | |
| Additional items | |||||||||||||||
| EPS (Basic) | -8.70 | -9.51 | -14.44 | -31.64 | -5.46 | -3.07 | -2.93 | -3.46 | -3.21 | 5.46 | -5.30 | -11.52 | -7.57 | -13.70 | |
| EPS (Diluted) | -31.64 | -5.46 | -3.07 | -2.93 | -3.46 | -3.21 | 5.46 | -5.30 | -11.52 | -7.57 | -13.70 | ||||
| Shares Outstanding | 0.04M | 0.11M | 0.10M | 0.10M | 0.13M | 0.47M | 0.58M | 0.58M | 0.56M | 0.61M | 0.64M | 3.06M | 1.88M | 3.31M | 3.54M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.13M | 0.47M | 0.58M | 0.58M | 0.56M | 0.61M | 0.64M | 3.06M | 1.88M | 3.31M | 3.54M | ||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.04M | 0.11M | 0.10M | 0.10M | 0.13M | 0.47M | 0.58M | 0.58M | 0.61M | 0.62M | 0.67M | 3.09M | 1.88M | 3.37M | 3.72M |
| EBITDA | -0.91M | -0.78M | -1.29M | -3.88M | -1.93M | -1.76M | -2.05M | -1.82M | -1.83M | -3.23M | -15.36M | -12.00M | -13.09M | -30.41M | |
| Interest ExpensesInt Expense | 0.04M | 0.11M | 0.13M | 0.22M | 1.35M | 1.31M | 2.35M | 4.74M | |||||||
| Tax Rate | 2.78% | 24.21% |